China · Delayed Price · Currency is CNY Huaren Pharmaceutical Statistics
Total Valuation
SHE:300110 has a market cap or net worth of CNY 3.92 billion. The enterprise value is 4.63 billion.
| Market Cap | 3.92B |
| Enterprise Value | 4.63B |
Important Dates
The next estimated earnings date is Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300110 has 1.18 billion shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 1.18B |
| Shares Outstanding | 1.18B |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | -0.25% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 9.82% |
| Float | 878.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.13 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 11.76 |
| P/FCF Ratio | 15.73 |
| P/OCF Ratio | 13.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 26.66, with an EV/FCF ratio of 18.54.
| EV / Earnings | -3.28 |
| EV / Sales | 3.68 |
| EV / EBITDA | 26.66 |
| EV / EBIT | 72.17 |
| EV / FCF | 18.54 |
Financial Position
The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.74 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 4.92 |
| Debt / FCF | 3.42 |
| Interest Coverage | 1.42 |
Financial Efficiency
Return on equity (ROE) is -65.96% and return on invested capital (ROIC) is 2.88%.
| Return on Equity (ROE) | -65.96% |
| Return on Assets (ROA) | 0.97% |
| Return on Invested Capital (ROIC) | 2.88% |
| Return on Capital Employed (ROCE) | 3.49% |
| Weighted Average Cost of Capital (WACC) | 6.06% |
| Revenue Per Employee | 504,139 |
| Profits Per Employee | -565,809 |
| Employee Count | 2,491 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.99 |
Taxes
| Income Tax | -981,616 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.44% in the last 52 weeks. The beta is 0.40, so SHE:300110's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | +7.44% |
| 50-Day Moving Average | 3.32 |
| 200-Day Moving Average | 3.33 |
| Relative Strength Index (RSI) | 51.42 |
| Average Volume (20 Days) | 26,289,459 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300110 had revenue of CNY 1.26 billion and -1.41 billion in losses. Loss per share was -1.19.
| Revenue | 1.26B |
| Gross Profit | 413.36M |
| Operating Income | 64.09M |
| Pretax Income | -1.41B |
| Net Income | -1.41B |
| EBITDA | 173.06M |
| EBIT | 64.09M |
| Loss Per Share | -1.19 |
Balance Sheet
The company has 222.89 million in cash and 853.03 million in debt, with a net cash position of -630.14 million or -0.53 per share.
| Cash & Cash Equivalents | 222.89M |
| Total Debt | 853.03M |
| Net Cash | -630.14M |
| Net Cash Per Share | -0.53 |
| Equity (Book Value) | 1.43B |
| Book Value Per Share | 1.15 |
| Working Capital | -400.29M |
Cash Flow
In the last 12 months, operating cash flow was 293.60 million and capital expenditures -44.12 million, giving a free cash flow of 249.48 million.
| Operating Cash Flow | 293.60M |
| Capital Expenditures | -44.12M |
| Free Cash Flow | 249.48M |
| FCF Per Share | 0.21 |
Margins
Gross margin is 32.92%, with operating and profit margins of 5.10% and -112.23%.
| Gross Margin | 32.92% |
| Operating Margin | 5.10% |
| Pretax Margin | -112.03% |
| Profit Margin | -112.23% |
| EBITDA Margin | 13.78% |
| EBIT Margin | 5.10% |
| FCF Margin | 19.87% |
Dividends & Yields
SHE:300110 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.08% |
| Shareholder Yield | 0.08% |
| Earnings Yield | -35.91% |
| FCF Yield | 6.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | May 31, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300110 has an Altman Z-Score of 1.37 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.37 |
| Piotroski F-Score | 5 |